Similar Articles
1761 Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment
1762 Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
1763 Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis
1764 ALK gene copy number gain and its clinical significance in hepatocellular carcinoma
1765 Epirubicin, Cisplatin, 5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma
1766 S-1-based combination therapy vs S-1 monotherapy in advanced gastric cancer: A meta-analysis
1767 Liver transplantation for hepatocellular carcinoma: Role of inflammatory and immunological state on recurrence and prognosis
1768 Transplant benefit for patients with hepatocellular carcinoma
1769 Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C
1770 Endoscopic sphincterotomy plus large-balloon dilation vs endoscopic sphincterotomy for choledocholithiasis: A meta-analysis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA